Cargando…
PB2335: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB PLUS CHOP (O-CHOP) VERSUS R-CHOP IN PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA (OLYMPIA-3)
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428936/ http://dx.doi.org/10.1097/01.HS9.0000976060.06798.be |
| _version_ | 1785090590083383296 |
|---|---|
| author | Tessoulin, Benoit Guidez, Stephanie Namuduri, Manjusha Risal3, Ashish Waldron, Alpana Sophos, Nickolas A. Uppala, Amulya Zhu, Min Nolan, Siobhán Brouwer-Visser, Jurriaan Chaudhry, Aafia Ambati, Srikanth Mohamed, Hesham Tucker, David |
| author_facet | Tessoulin, Benoit Guidez, Stephanie Namuduri, Manjusha Risal3, Ashish Waldron, Alpana Sophos, Nickolas A. Uppala, Amulya Zhu, Min Nolan, Siobhán Brouwer-Visser, Jurriaan Chaudhry, Aafia Ambati, Srikanth Mohamed, Hesham Tucker, David |
| author_sort | Tessoulin, Benoit |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428936 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104289362023-08-17 PB2335: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB PLUS CHOP (O-CHOP) VERSUS R-CHOP IN PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA (OLYMPIA-3) Tessoulin, Benoit Guidez, Stephanie Namuduri, Manjusha Risal3, Ashish Waldron, Alpana Sophos, Nickolas A. Uppala, Amulya Zhu, Min Nolan, Siobhán Brouwer-Visser, Jurriaan Chaudhry, Aafia Ambati, Srikanth Mohamed, Hesham Tucker, David Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428936/ http://dx.doi.org/10.1097/01.HS9.0000976060.06798.be Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Tessoulin, Benoit Guidez, Stephanie Namuduri, Manjusha Risal3, Ashish Waldron, Alpana Sophos, Nickolas A. Uppala, Amulya Zhu, Min Nolan, Siobhán Brouwer-Visser, Jurriaan Chaudhry, Aafia Ambati, Srikanth Mohamed, Hesham Tucker, David PB2335: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB PLUS CHOP (O-CHOP) VERSUS R-CHOP IN PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA (OLYMPIA-3) |
| title | PB2335: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB PLUS CHOP (O-CHOP) VERSUS R-CHOP IN PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA (OLYMPIA-3) |
| title_full | PB2335: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB PLUS CHOP (O-CHOP) VERSUS R-CHOP IN PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA (OLYMPIA-3) |
| title_fullStr | PB2335: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB PLUS CHOP (O-CHOP) VERSUS R-CHOP IN PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA (OLYMPIA-3) |
| title_full_unstemmed | PB2335: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB PLUS CHOP (O-CHOP) VERSUS R-CHOP IN PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA (OLYMPIA-3) |
| title_short | PB2335: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB PLUS CHOP (O-CHOP) VERSUS R-CHOP IN PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA (OLYMPIA-3) |
| title_sort | pb2335: trial in progress: phase 3 trial evaluating the efficacy and safety of odronextamab plus chop (o-chop) versus r-chop in previously untreated diffuse large b-cell lymphoma (olympia-3) |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428936/ http://dx.doi.org/10.1097/01.HS9.0000976060.06798.be |
| work_keys_str_mv | AT tessoulinbenoit pb2335trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabpluschopochopversusrchopinpreviouslyuntreateddiffuselargebcelllymphomaolympia3 AT guidezstephanie pb2335trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabpluschopochopversusrchopinpreviouslyuntreateddiffuselargebcelllymphomaolympia3 AT namudurimanjusha pb2335trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabpluschopochopversusrchopinpreviouslyuntreateddiffuselargebcelllymphomaolympia3 AT risal3ashish pb2335trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabpluschopochopversusrchopinpreviouslyuntreateddiffuselargebcelllymphomaolympia3 AT waldronalpana pb2335trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabpluschopochopversusrchopinpreviouslyuntreateddiffuselargebcelllymphomaolympia3 AT sophosnickolasa pb2335trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabpluschopochopversusrchopinpreviouslyuntreateddiffuselargebcelllymphomaolympia3 AT uppalaamulya pb2335trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabpluschopochopversusrchopinpreviouslyuntreateddiffuselargebcelllymphomaolympia3 AT zhumin pb2335trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabpluschopochopversusrchopinpreviouslyuntreateddiffuselargebcelllymphomaolympia3 AT nolansiobhan pb2335trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabpluschopochopversusrchopinpreviouslyuntreateddiffuselargebcelllymphomaolympia3 AT brouwervisserjurriaan pb2335trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabpluschopochopversusrchopinpreviouslyuntreateddiffuselargebcelllymphomaolympia3 AT chaudhryaafia pb2335trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabpluschopochopversusrchopinpreviouslyuntreateddiffuselargebcelllymphomaolympia3 AT ambatisrikanth pb2335trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabpluschopochopversusrchopinpreviouslyuntreateddiffuselargebcelllymphomaolympia3 AT mohamedhesham pb2335trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabpluschopochopversusrchopinpreviouslyuntreateddiffuselargebcelllymphomaolympia3 AT tuckerdavid pb2335trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabpluschopochopversusrchopinpreviouslyuntreateddiffuselargebcelllymphomaolympia3 |